Publications by authors named "James Talks"

Claim this Profile
D
Deep Learning Algorithm for the Diagnosis and Prediction of Hydroxychloroquine Retinopathy: An International, Multi-institutional Study.
Peter Woodward-Court, Jeffry Hogg, Terry Lee, Priyal Taribagil, Cindy S Zhao, James Talks

Ophthalmol Retina· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study.
Tunde Peto, Ian Pearce, James Talks, Gabriella de Salvo, Praveen J Patel

Eye (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and standardisation of 'time-in-range' measurement for clinical endpoints in retinal diseases.
Luisa Frizziero, Jane Barratt, Chui Ming Gemmy Cheung, Andrii Korol, Edoardo Midena, James Talks

Eye (Lond)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual site external validation of artificial intelligence-enabled treatment monitoring for neovascular age-related macular degeneration in England.
Henry David Jeffry Hogg, S James Talks, Justin Engelmann, Marion Dawn Teare, Michael Pogose

Eye (Lond)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-year results from an observational study of proactive treatment regimens with intravitreal aflibercept 2 mg in patients with nAMD in clinical practice: XTEND study UK cohort.
Clare Bailey, Manju Chandran, Richard Gale, Nirodhini Narendran, James Talks

Eye (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff.
Focke Ziemssen, Michelle Sylvanowicz, Winfried M Amoaku, Tariq Aslam, Bora Eldem, S James Talks

Ophthalmol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration.
Anat Loewenstein, Michelle Sylvanowicz, Winfried M Amoaku, Tariq Aslam, Chui Ming Gemmy Cheung, S James Talks

Ophthalmol Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept.
Nirodhini Narendran, Clare Bailey, Louise Downey, Richard Gale, Ajay Kotagiri, James Talks

Clin Ophthalmol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intervention design for artificial intelligence-enabled macular service implementation: a primary qualitative study.
Henry David Jeffry Hogg, Katie Brittain, James Talks, Pearse Andrew Keane,

Implement Sci Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5.
Sridevi Thottarath, Sarega Gurudas, Swati Chandak, Praveen J Patel, Ajay Kotagiri, James Talks

Eye (Lond)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subretinal transient hyporeflectivity in neovascular age-related macular degeneration and its response to a loading phase of aflibercept: PRECISE report 4.
Andrea Montesel, Raheeba Pakeer Muhammed, Swati Chandak, Dimitrios Kazantzis, Sridevi Thottarath, James Talks

Eye (Lond)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world service costs for neovascular-AMD clinics in the United Kingdom: structured literature review and scenario analysis.
Sobha Sivaprasad, Clare Bailey, Louise Downey, Rose Gilbert, Richard Gale, James Talks

Curr Med Res Opin· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline characteristics of eyes with early residual fluid post loading phase of aflibercept therapy in neovascular AMD: PRECISE study report 3.
Shruti Chandra, Sarega Gurudas, Ian Pearce, Martin Mckibbin, Ajay Kotagiri, James Talks

Eye (Lond)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of presenting visual acuity with morphological changes on OCT in neovascular age-related macular degeneration: PRECISE Study Report 2.
Shruti Chandra, Sarega Gurudas, Benjamin J L Burton, Geeta Menon, Ian Pearce, James Talks

Eye (Lond)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sickle Eye Project: a cross-sectional, non-interventional study of the prevalence of visual impairment due to sickle cell retinopathy and maculopathy in the UK.
Christiana Dinah, Konstantinos Balaskas, Brigit Greystoke, Rossby Awadzi, Peter Beke, James Talks

BMJ Open· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes.
Sobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, Ajay Kotagiri, James Talks

Eye (Lond)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of standard-of-care intravitreal aflibercept treatment practices in patients with diabetic macular oedema in the UK: DRAKO study outcomes.
Sobha Sivaprasad, Faruque Ghanchi, Simon P Kelly, Ajay Kotagiri, James Talks

Eye (Lond)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multi-Modal AI-Driven Cohort Selection Tool to Predict Suboptimal Non-Responders to Aflibercept Loading-Phase for Neovascular Age-Related Macular Degeneration: PRECISE Study Report 1.
Michal Chorev, Jonas Haderlein, Shruti Chandra, Geeta Menon, Benjamin J L Burton, James Talks

J Clin Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Patient Voice in Neovascular Age-Related Macular Degeneration: Findings from a Qualitative Study.
S James Talks, Vincent Daien, Paul Mitchell, Tariq Aslam, Jane Barratt

Ophthalmol Ther· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of an artificial intelligence-enabled decision tool for treatment decisions in neovascular age-related macular degeneration and an exploration of clinical pathway integration and implementation: protocol for a multi-methods validation study.
Henry David Jeffry Hogg, Katie Brittain, Dawn Teare, James Talks, Konstantinos Balaskas

BMJ Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetic Macular Edema and Diode Subthreshold Micropulse Laser: A Randomized Double-Masked Noninferiority Clinical Trial.
Noemi Lois, Christina Campbell, Norman Waugh, Augusto Azuara-Blanco, Mandy Maredza, James Stephen Talks

Ophthalmology· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stakeholder Perspectives of Clinical Artificial Intelligence Implementation: Systematic Review of Qualitative Evidence.
Henry David Jeffry Hogg, Mohaimen Al-Zubaidy, , James Talks, Alastair K Denniston

J Med Internet Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
Noemi Lois, Christina Campbell, Norman Waugh, Augusto Azuara-Blanco, Mandy Maredza, James Stephen Talks

Health Technol Assess· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing landscape for the management of patients with neovascular AMD: brolucizumab in clinical practice.
Ian Pearce, Winfried Amoaku, Clare Bailey, Louise Downey, Richard Gale, James Talks

Eye (Lond)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stakeholder Perspectives on Clinical Decision Support Tools to Inform Clinical Artificial Intelligence Implementation: Protocol for a Framework Synthesis for Qualitative Evidence.
Mohaimen Al-Zubaidy, H D Jeffry Hogg, Gregory Maniatopoulos, James Talks, Marion Dawn Teare

JMIR Res Protoc· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis